Clinical Trial Update: Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer

View source ↗

Summary

ClinicalTrials.gov entry describing a study evaluating the diagnostic performance of the radiotracer [18F]PSMA-1007 for detecting recurrent prostate cancer in p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA-1007 (PSMA-1007 radiotracer)

Snippet

Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Prostate Cancer After a Radical Treatment, Biochemical Recurrence of Malignant Neoplasm of Prostate | Status: RECRUITING